Total and out-of-pocket costs of different primary management strategies in ovarian cancer.

08:00 EDT 6th April 2019 | BioPortfolio

Summary of "Total and out-of-pocket costs of different primary management strategies in ovarian cancer."

Communicating healthcare costs to patients is an important component of delivering high-quality value-based care, yet cost data is lacking. This is especially relevant for ovarian cancer, where no clinical consensus on optimal first-line treatment exists.


Journal Details

This article was published in the following journal.

Name: American journal of obstetrics and gynecology
ISSN: 1097-6868


DeepDyve research library

PubMed Articles [25031 Associated PubMed Articles listed on BioPortfolio]

Costs of an Aedes aegypti vector control program in municipalities in Colombia: a case study in Girón and Guadalajara de Buga, 2016.

The aim of this study was to measure the costs of vector-borne disease control programs at the local level in Colombia (2016). A cost analysis was performed for this purpose from the policymaker's per...

Health Insurance and Out-of-Pocket Costs in the Last Year of Life Among Decedents Utilizing the ICU.

Use of intensive care is increasing in the United States and may be associated with high financial burden on patients and their families near the end of life. Our objective was to estimate out-of-pock...

Are fishery management upgrades worth the cost?

Many analyses of fishery recovery have demonstrated the potential biological and economic benefits of management reform, but few have compared these to the associated costs of management upgrades, whi...

In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO Registry.

The aim of this study was to describe the costs of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) and the association of complications during CTO PCI with costs and length of s...

The prevalence of primary ovarian insufficiency in Sweden; a national register study.

The current estimates of the prevalence of primary ovarian insufficiency (POI) are very variable, but are in most studies believed to be around 1%. It is also very likely tat the prevalence of POI dif...

Clinical Trials [13125 Associated Clinical Trials listed on BioPortfolio]

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

The primary objective of this study is to apply best-practice stated-preference methods to quantify the extent to which women with ovarian cancer accept the risks, side effects, and out-of...

Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France

No structured organization for ovarian first line management emerges in France. Management across France seems to depend on regional contexts. Regions display no specific organization or ...

HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

Huntington's disease (HD) is a progressive, rare neurodegenerative disorder for which hallmark symptoms include movement disorders, loss of cognitive faculties and psychiatric disturbances...

Investigation of the Safety and Efficacy of Pocket-X Gel and Pocket-X Chip

This study is a prospective randomized open-label controlled study in which the Pocket-X Gel, a periodontal in-situ gelling product, or Pocket-X Chip, a periodontal film, will be applied t...

Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy

The purpose of this study is to compare the clinical outcomes and costs associated with two different management strategies for patients with acute low back pain who consult their primary ...

Medical and Biotech [MESH] Definitions

That portion of total HEALTH CARE COSTS borne by an individual's or group's employing organization.

Management control systems for structuring health care delivery strategies around case types, as in DRGs, or specific clinical services.

Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections.

The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (From Dictionary of Health Services Management, 2d ed)

The amounts spent by individuals, groups, nations, or private or public organizations for total health care and/or its various components. These amounts may or may not be equivalent to the actual costs (HEALTH CARE COSTS) and may or may not be shared among the patient, insurers, and/or employers.

Quick Search


DeepDyve research library

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Searches Linking to this Article